v3.26.1
STOCK BASED COMPENSATION EXPENSE
6 Months Ended
Jun. 30, 2026
STOCK BASED COMPENSATION EXPENSE  
STOCK BASED COMPENSATION EXPENSE

7.

STOCK BASED COMPENSATION EXPENSE

Equity incentive plans

As of June 30, 2026, the Company had adopted three equity incentive plans in 2007 (the “2007 Plan”), 2017 (the “2017 Plan”) and 2024 (the “2024 Plan, and together with the 2007 Plan and the 2017 Plan, the “Stock Plans”) to provide for the grant of stock options, stock appreciation rights (“SARs”), restricted stock, restricted stock units and other stock or cash-based awards to our directors, employees, non-employee directors and service providers. Equity awards are granted with an exercise price per share equal to at least the estimated fair value of the underlying common stock on the date of grant. The vesting period is determined through individual award agreements. Awards generally expire 10 years from the date of grant.

As of June 30, 2026, a total of 347,695 shares were authorized for issuance under the Stock Plans. As of June 30, 2026, 328,785 shares have been granted or issued under the Stock Plans, leaving 18,910 shares available for future awards. As of December 31, 2025, there were 239,208 shares granted under the 2007 Plan and the 2017 Plan. The shares available for issuance under the 2024 Plan may consist, in whole or in part, of authorized and unissued shares or reacquired shares. Shares from the 2024 Plan which are forfeited due to employee termination or expiration are returned to the share pool. Similarly, shares from the 2024 Plan which are withheld upon exercise to provide for the exercise price and/or taxes due and shares repurchased by the Company are also returned to the pool.

Since December 6, 2024, we have not granted and do not intend to grant any further awards under the 2007 Plan or the 2017 Plan.

Time-Based Restricted Stock

Time-based restricted stock units (RSUs) granted to employees under the 2024 Plan typically vest over one to three years and are subject to forfeiture if employment terminates prior to the vesting or lapse of restrictions, as applicable. RSUs are not considered outstanding Common Stock until they vest. The value of RSUs is determined by the stock price on the grant date.

The following table summarizes the activity related to RSUs subject to time-based vesting requirements for the six months ended June 30, 2026:

RSUs

Number of Shares

Weighted Average Grant Date Fair Value

Non-vested as of December 31, 2025

35,818

$

328.25

Granted

43,301

2.77

Vested

(9,955)

279.51

Forfeited

(2,837)

311.66

Non-vested as of June 30, 2026

66,327

$

13.56

As of June 30, 2026, total unrecognized stock-based compensation cost for RSUs was approximately $7.3 million which is expected to be recognized on a straight-line basis over a weighted average period of 1.4 years. The intrinsic value of RSUs as of June 30, 2026 was approximately $14,000.

Determination of fair value of stock options

As of June 30, 2026 and December 31, 2025, the Company had approximately 0.2 million options outstanding under the 2007 Plan and the 2017 Plan. As of June 30, 2026 and December 31, 2025, all options outstanding were granted solely with time-based vesting requirements.

A summary of the Company’s stock option plan and the changes during the period ended June 30, 2026 is presented below:

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Weighted

  ​ ​ ​

 

Weighted

Average

 

Number of

Average 

Remaining 

Aggregate 

 

Outstanding

Exercise 

Contractual 

Intrinsic 

 

Options

Price

Years

Value

 

Balance, December 31, 2025

 

234,147

$

75.00

 

7.00

 

  ​

Expired

 

(31)

15,000.00

 

 

  ​

Forfeited

(32,453)

67.45

Balance, June 30, 2026

 

201,663

$

74.77

 

6.50

$

(1)

Vested and Exercisable, June 30, 2026

 

201,561

$

75.09

 

6.41

$

(1)

Vested and Expected to Vest, June 30, 2026

 

201,663

$

74.77

 

6.50

$

(1)

(1) The Company’s closing stock price as of June 30, 2026 is $0.21 per share. As all outstanding options have an exercise price greater than the closing price, there does not exist any intrinsic value as of June 30, 2026.

As of June 30, 2026, there was no significant unrecognized stock-based compensation cost for stock options granted.

Stock-based compensation included in the condensed consolidated statements of operations was as follows:

Three Months Ended June 30, 

Six Months Ended June 30, 

 

2026

  ​ ​ ​

2025

2026

  ​ ​ ​

2025

Cost of goods sold

$

21

$

25

$

40

$

32

Research and development

 

85

122

166

177

Selling and marketing

 

399

504

 

782

 

809

General and administrative

1,087

1,192

 

2,155

1,810

Total stock-based compensation expense

 

$

1,592

$

1,843

$

3,143

$

2,828